No Data
No Data
Express News | Acumen Pharmaceuticals Inc : UBS Cuts Target Price to $6 From $14
Express News | UBS Maintains Buy on Acumen Pharmaceuticals, Lowers Price Target to $6
Acument Pharmaceuticals Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness After the Company Reported Worse-than-expected Q2 EPS Results Yesterday.
Express News | Acument Pharmaceuticals Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness After the Company Reported Worse-than-expected Q2 EPS Results Yesterday
BTIG Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating, Maintains Target Price $11
H.C. Wainwright Maintains Acumen Pharmaceuticals(ABOS.US) With Buy Rating, Maintains Target Price $15
Lnova : Thank you for sharing